Bloomberg
-
North Wales-based Teva Pharmaceuticals seeks to reduce debt
The world’s biggest manufacturer of generic drugs is seeking to shrink its $35 billion in debt, according to Bloomberg, as it…
-
Vanguard Group testing new waters
Vanguard Group, the Malvern-based investment giant that manages close to $5 trillion in clients’ money, said Tuesday that it has registered a plan with…
-
Bloomberg: Turnpike a Contender for Trump’s Public and Private Infrastructure Partnership
Pennsylvania Turnpike is looking to take advantage of President Trump’s push to attract private investors into infrastructure rehabilitation, writes Gillian…
-
Upper Merion High School Alum, Soon-to-be Congressman Used to Be Godfather of Montana Technology Scene
Congressman Greg Gianforte, famous for body slamming a reporter on the eve of his election, is also the founder of…
-
Vanguard Cautious About Record-High Stocks
Vanguard Group, based a few miles west of King of Prussia in Chester County, has benefitted more than most from…
-
Robots Kill Jobs, and So Do Companies That Don’t Automate
It’s kind of a catch-22. The medium-sized increase in the use of industrial robots across suburban Philadelphia in the 1990s…
-
GlaxoSmithKline CEO: New Drugs Must Be Both Innovative and Affordable
Drug pricing, regulations, and possible Medicaid price negotiations are among the subjects GlaxoSmithKline’s CEO Andrew Witty recently discussed in a…
-
Bloomberg: Trump’s Immigration Policies Could Adversely Affect Pennsylvania’s Economy
Despite his promise of economic prosperity, Donald Trump and his much-vaunted tightening of immigration policies could mean there are fewer…
-
GlaxoSmithKline’s Collegeville Facility Gambling on Antibiotics
GlaxoSmithKline’s Collegeville facility is leading the charge against superbugs with cutting edge antibacterial research, writes Stephanie Baker for Bloomberg. Most…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
